Iovate Health Sciences International Inc   Report issue

For profit Phase 1 Phase 2
Founded: Oakville Canada (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2006
NCT01444170
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Iovate Health Sciences International Inc

Active Ingredients

Drugs in Phase 2 Trials (1)

dicreatinol sulfate (1 trial)

Drugs in Phase 1 Trials (2)

branched chain amino acids (1 trial)

essential amino acids (1 trial)

Drugs in Other Trials (1)

testosterone (delatestryl) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4